Why are there so few doctors in Los Angeles?
Pharma marketers are accustomed to worrying about “white space” coverage—getting to physicians who aren’t assigned a sales rep, based on geography; now they need to worry about what might be called “medical white space”—geographies with limited access to physicians themselves. It’s not a new phenomenon, but with the expansion of healthcare coverage coming with the Affordable Care Act, and with a growing emphasis by pharma on connecting to patients, the paucity of physicians will be a new obstacle.
Vitals (Lyndhurst, NJ), operators of the Vitals.com website that links consumers to healthcare practitioners (HCPs), says that its Vitals Index, a proprietary database, shows that physician access ranges from 82.79 consumers/physician, in Boston, to 642.34 in Arlington, TX. The survey, across the 50 major metropolitan areas in the US, finds the greatest per capita concentration, after Boston, in Miami, Atlanta, Minneapolis and Cleveland; the five worst are San Jose, CA, Virginia Beach, VA, Los Angeles, El Paso and Arlington.
These disparities are a concern, of course, for healthcare policymakers and public health generally, but for the pharma industry, they will call for greater sophistication in connecting with other parts of the healthcare system besides physicians. “Nurse practitioners and physician associates will take on a more important role in diagnosing and treating patients,” suggests Mitch Rothschild, Vitals CEO. “Retail clinics and urgent care facilities will become the norm for routine care. Even medical tourism is likely to see a boon as patients plan vacations around treatments abroad, rather than wait for openings in a surgeon’s tight schedule.”
The Vitals portal (which accepts pharma industry advertising itself) is accessed by 150 million US consumers annually, says the company. Visitors can review information on specific disease states, and select doctors by location, specialty and insurance acceptance.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.